Managing chronic obstructive pulmonary disease

Australian Prescriber

Volumn 30, Issue 3, 2007, Pages 64-67

  Abramson, Michael ^a   Glasgow, Nicholas ^b   McDonald, Christine ^c  

^a MONASH UNIVERSITY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Bronchodilators; Corticosteroids; Pulmonary rehabilitation

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; HYDROCORTISONE; PREDNISOLONE; SALMETEROL; TIOTROPIUM BROMIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; OXYGEN THERAPY; PULMONARY REHABILITATION; REVIEW; SPIROMETRY;

EID: 34249799920     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2007.038     Document Type: Review

References (11)

1. McKenzie DK, Frith PA, Burdon JGW, Town GI. The COPDX plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. Med J Aust 2003;178(6 Suppl):S1-S40.
2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; Gold Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001;163:1256-76.
3. Abramson MJ, Crockett AJ, Frith PA, McDonald CF. COPDX: an update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. Med J Aust 2006;184:342-5.
4. Borrill Z, Houghton C, Sullivan PJ, Sestini P. Retrospective analysis of evidence base for tests used in diagnosis and monitoring of disease in respiratory medicine. BMJ 2003;327:1136-8.
5. Salpeter SR, Buckley NS, Salpeter EE. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med 2006;21:1011-9.
6. Suissa S. Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:842-6.
7. Decramer M, De Benedetto F, Del Ponte A, Marinari S. Systemic effects of COPD. Respir Med 2005;99(Suppl B): S3-S10.
8. http://www.pulmonaryrehab.com.au [cited 2007 May 14]
9. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-73. [randomised trial]
10. Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005;60:992-7.
11. The Australian Immunisation Handbook. 8th ed. 2003. http://www9.health. gov.au/immhandbook/ [cited 2007 May 14]